PlexBio Co (ROCO:6572) Total Equity: NT$310.4 Mil (As of Dec. 2025)


ROCO:6572 PlexBio Co Ltd ROCO:6572
67 GF Score
Price NT$7.62
GF Value NT$9.52
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is PlexBio Co Total Equity?

PlexBio Co ROCO:6572 67 Total Equity is NT$310.4 Mil as of Dec. 2025. GuruFocus rates ROCO:6572 with a GF Score™ of 67/100 and a GF Value™ of NT$9.52 (Modestly Undervalued). The stock has 4 warning signs investors should review.

PlexBio Co's total equity for the quarter that ended in Dec. 2025 was NT$310.4 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


PlexBio Co Total Equity Historical Data

* Premium members only.

The historical data trend for PlexBio Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PlexBio Co Total Equity Chart

PlexBio Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 534.32 479.43 424.40 374.41 310.44

PlexBio Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 424.40 384.34 374.41 327.65 310.44
ROCO:6572
67GF Score
PlexBio Co Ltd ROCO:6572
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PlexBio Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

PlexBio Co's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=446.587-136.146
=310.4

PlexBio Co's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=446.587-136.146
=310.4

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of NT$310.4 Mil mean?
PlexBio Co (ROCO:6572) has a Total Equity of NT$310.4 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for PlexBio Co and its competitors.
Is PlexBio Co's Total Equity too high?
PlexBio Co's current Total Equity is NT$310.4 Mil. Overall, PlexBio Co has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PlexBio Co's Total Equity compare to ABT and SYK?
PlexBio Co's Total Equity of NT$310.4 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for PlexBio Co and its competitors. PlexBio Co's current Total Equity is NT$310.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PlexBio Co stock overvalued right now?
Based on GuruFocus' analysis, PlexBio Co (ROCO:6572) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$9.52, compared to a current price of NT$7.62 — trading 20% below its estimated fair value. The current Total Equity is NT$310.4 Mil. PlexBio Co's overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For PlexBio Co (ROCO:6572), the current Total Equity is NT$310.4 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PlexBio Co (ROCO:6572) Overvalued in 2026?

Based on GuruFocus' analysis, PlexBio Co stock appears to be undervalued. The current stock price of NT$7.62 is trading 20% below its estimated GF Value™ of NT$9.52. GuruFocus considers PlexBio Co to be Modestly Undervalued.

Key valuation signals for ROCO:6572:

  • Total Equity: NT$310.4 Mil
  • GF Value™: NT$9.52 vs. price of NT$7.62 (20% below fair value)
  • GF Score™: 67/100 with 4 warning signs

No single metric tells the full story. See the ROCO:6572 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PlexBio Co Business Description

Address 6F-1, Number 351, Yangguang Street, Neihu District, Taipei, TWN, 11491
PlexBio Co Ltd is a Taiwan based company involved in designing, developing and manufacturing IVD products and instrumentations. Its products are used in companion diagnostic panel, early cancer detection screening, prenatal diagnostics and for food and safety testing.
67GF Score

Get the complete analysis for ROCO:6572

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$7.62
Price
NT$9.52
GF Value